We report here that the tat gene product of human immunodeficiency virus type 1 was able to protect lymphoblastoid (Jurkat), epithelial (293) and neuronal (PC12) cell lines from apoptotic death induced by serum withdrawal. The rescue from apoptosis by Tat was reflected by an increased expression of Bcl-2 protein in tat-positive Jurkat cells with respect to mock-transfected Jurkat cells after 3-6 days of serum-free cultures. We propose that the ability of the regulatory human immunodeficiency virus type 1 Tat protein to suppress apoptosis might have important implications in understanding the pathogenesis of frequent neoplastic disorders observed in human immunodeficiency virus type 1-seropositive individuals
The Tat protein of the human immunodeficiency virus type 1 promotes survival and growth and inhibits...
During acute human immunodeficiency virus type 1 (HIV-1) infection or after transfection of the tat ...
Background: Tat is being tested as a component of HIV vaccines. Tat activity has been mainly investi...
The regulatory Tat protein of human immunodeficiency virus type-1 (HIV-1) exerts a pleyotropic activ...
Patients infected with human immunodeficiency virus type 1 (HIV-1) develop a spectrum of B cell lymp...
We have here investigated the effect of TNF-related apoptosis-inducing ligand (TRAIL), a new member ...
Human CD4+ T lymphoblastoid Jurkat cells were stably transfected with two different plasmid vectors ...
Human CD4+ T lymphoblastoid Jurkat cells were stably transfected with two different plasmid vectors ...
AbstractHuman immunodeficiency virus type 1 (HIV-1) Tat transcriptionally activates expression from ...
Human immunodeficiency virus type 1 (HIV-1) transactivating Tat protein is pivotal to virus replicat...
AbstractThe Tat protein of the human immunodeficiency virus type 1 promotes survival and growth and ...
In this study, we showed the existence of a positive correlation between the amount of human immunod...
none8In this study, we showed the existence of a positive correlation between the amount of human im...
HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codif...
AbstractThe human immunodeficiency virus type 1 (HIV-1) genome codes for trans-activator Tat, an 86-...
The Tat protein of the human immunodeficiency virus type 1 promotes survival and growth and inhibits...
During acute human immunodeficiency virus type 1 (HIV-1) infection or after transfection of the tat ...
Background: Tat is being tested as a component of HIV vaccines. Tat activity has been mainly investi...
The regulatory Tat protein of human immunodeficiency virus type-1 (HIV-1) exerts a pleyotropic activ...
Patients infected with human immunodeficiency virus type 1 (HIV-1) develop a spectrum of B cell lymp...
We have here investigated the effect of TNF-related apoptosis-inducing ligand (TRAIL), a new member ...
Human CD4+ T lymphoblastoid Jurkat cells were stably transfected with two different plasmid vectors ...
Human CD4+ T lymphoblastoid Jurkat cells were stably transfected with two different plasmid vectors ...
AbstractHuman immunodeficiency virus type 1 (HIV-1) Tat transcriptionally activates expression from ...
Human immunodeficiency virus type 1 (HIV-1) transactivating Tat protein is pivotal to virus replicat...
AbstractThe Tat protein of the human immunodeficiency virus type 1 promotes survival and growth and ...
In this study, we showed the existence of a positive correlation between the amount of human immunod...
none8In this study, we showed the existence of a positive correlation between the amount of human im...
HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codif...
AbstractThe human immunodeficiency virus type 1 (HIV-1) genome codes for trans-activator Tat, an 86-...
The Tat protein of the human immunodeficiency virus type 1 promotes survival and growth and inhibits...
During acute human immunodeficiency virus type 1 (HIV-1) infection or after transfection of the tat ...
Background: Tat is being tested as a component of HIV vaccines. Tat activity has been mainly investi...